ContraFect Corp Share Price Nasdaq
Equities
US2123262014
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
03/05 | North American Morning Briefing : Apple, Amgen -2- | DJ |
26/04 | North American Morning Briefing : Tech Still in -2- | DJ |
Sales 2021 | - | Sales 2022 | - | Capitalization | 41.94L 35Cr |
---|---|---|---|---|---|
Net income 2021 | -2Cr -166.52Cr | Net income 2022 | -6.5Cr -541.2Cr | EV / Sales 2021 | - |
Net cash position 2021 | 5.1Cr 424.79Cr | Net cash position 2022 | 1.08Cr 90Cr | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.77
x | P/E ratio 2022 |
-0.06
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99.98% |
1st Jan change | Capi. | |
---|---|---|
-0.09% | 4.21TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.92TCr | |
+11.18% | 2.6TCr | |
-21.95% | 1.89TCr | |
+8.61% | 1.32TCr | |
+24.73% | 1.22TCr | |
+28.31% | 1.22TCr | |
-6.26% | 1.14TCr |